Login to Your Account

Pharma: Other News To Note

Tuesday, April 10, 2012
• Illumina Inc., of San Diego, urged stockholders to reject acquisition efforts by Basel, Switzerland-based Roche AG, and to vote for Illumina's slate of director nominees at the 2012 annual stockholders' meeting April 18. It called Roche's offer a "hostile bid to buy Illumina at a low-ball price." Roche has presented its own list of director nominees for election to Illumina's board.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription